[{
  "caption": "Figure 3. Cohort #2: hGRPs with FK-506/Rapamycin occupied a significant portion of the cervical spinal cord in SOD1G93A mice. Human GRP transplant-derived cells (from 4 injection sites: bilaterally at C4 and C5) dispersed to occupy a significant portion of the cervical spinal cord, as demonstrated by the sagittal series of HuNA-stained sections from a single animal (slices are approximately 200 mm apart). Scale bar: 500 mm. doi:10.1371/journal.pone.0025968.g003",
  "captionBoundary": {
    "x1": 58.051727294921875,
    "x2": 554.2525024414062,
    "y1": 699.5042724609375,
    "y2": 730.3182373046875
  },
  "figType": "Figure",
  "imageText": [],
  "name": "3",
  "page": 5,
  "regionBoundary": {
    "x1": 57.599999999999994,
    "x2": 411.35999999999996,
    "y1": 526.56,
    "y2": 685.92
  },
  "renderDpi": 150,
  "renderURL": "C:\\Users\\MSI\\OneDrive\\Documents\\Desktop\\5idma\\FrontBackPFE\\back\\output\\upload_1748292194_23796_pone.0025968\\image\\upload_1748292194_23796_pone.0025968-Figure3-1.png"
}, {
  "caption": "Figure 8. Cohort #2: hGRPs with FK-506/Rapamycin differentiated towards the oligodendrocyte lineage in SOD1G93A cervical spinal cord. At disease endstage, HuNA+ cells co-labeled with the oligodendrocyte lineage marker, Olig2 (A–B). Close to the injection sites, approximately 10–30% of the HuNA+ cells expressed Olig2, in both gray and white matter regions (C). This percentage was higher at greater distances from the injection sites. Scale bars: 50 mm. doi:10.1371/journal.pone.0025968.g008",
  "captionBoundary": {
    "x1": 58.05181884765625,
    "x2": 554.2764282226562,
    "y1": 690.7169189453125,
    "y2": 730.5450439453125
  },
  "figType": "Figure",
  "imageText": [],
  "name": "8",
  "page": 10,
  "regionBoundary": {
    "x1": 57.599999999999994,
    "x2": 382.08,
    "y1": 363.84,
    "y2": 677.28
  },
  "renderDpi": 150,
  "renderURL": "C:\\Users\\MSI\\OneDrive\\Documents\\Desktop\\5idma\\FrontBackPFE\\back\\output\\upload_1748292194_23796_pone.0025968\\image\\upload_1748292194_23796_pone.0025968-Figure8-1.png"
}, {
  "caption": "Figure 12. Cohort #3: ‘‘high dose’’ hGRP transplantation with FK-506/Rapamycin did not promote functional efficacy. Compared to control ‘‘high dose’’ transplantation of hFs, ‘‘high dose’’ hGRP transplants in combination with FK-506 and Rapamycin-based immune suppression neither accelerated nor slowed progression of disease in SOD1G93A mice. Unchanged outcome measures included weight loss (A), overall survival (B), declines in hindlimb (C) and forelimb (D) grip strength, hindlimb (E) and forelimb (F) disease onsets, and disease duration (G). doi:10.1371/journal.pone.0025968.g012",
  "captionBoundary": {
    "x1": 59.467681884765625,
    "x2": 555.6333618164062,
    "y1": 691.907470703125,
    "y2": 731.6790771484375
  },
  "figType": "Figure",
  "imageText": [],
  "name": "12",
  "page": 14,
  "regionBoundary": {
    "x1": 58.559999999999995,
    "x2": 482.4,
    "y1": 45.6,
    "y2": 679.1999999999999
  },
  "renderDpi": 150,
  "renderURL": "C:\\Users\\MSI\\OneDrive\\Documents\\Desktop\\5idma\\FrontBackPFE\\back\\output\\upload_1748292194_23796_pone.0025968\\image\\upload_1748292194_23796_pone.0025968-Figure12-1.png"
}, {
  "caption": "Figure 4. Cohort #2: hGRPs with FK-506/Rapamycin continued to proliferate in SOD1G93A cervical spinal cord. Approximately 10% of transplant-derived HuNA+ cells continued to divide at disease endstage, as determined by co-expression of the proliferation marker, Ki67 (A–B). No differences were noted between gray and white matter (C–D), and the percentage of proliferating cells slightly increased with distance from injection sites (E). Scale bars: 25 mm. doi:10.1371/journal.pone.0025968.g004",
  "captionBoundary": {
    "x1": 58.05242919921875,
    "x2": 554.260986328125,
    "y1": 691.0570678710938,
    "y2": 730.885009765625
  },
  "figType": "Figure",
  "imageText": [],
  "name": "4",
  "page": 6,
  "regionBoundary": {
    "x1": 57.599999999999994,
    "x2": 382.08,
    "y1": 232.79999999999998,
    "y2": 678.24
  },
  "renderDpi": 150,
  "renderURL": "C:\\Users\\MSI\\OneDrive\\Documents\\Desktop\\5idma\\FrontBackPFE\\back\\output\\upload_1748292194_23796_pone.0025968\\image\\upload_1748292194_23796_pone.0025968-Figure4-1.png"
}, {
  "caption": "Figure 7. Cohort #2: hGRPs did not express the astrocyte glutamate transporter GLT1 in SOD1G93A cervical spinal cord. Immunohistochemical analysis human GRP transplant-derived cells does not reveal expression of the astrocyte glutamate transporter, GLT1, in the SOD1G93A spinal cord at disease endstage (A–C). Intraspinal levels of GLT1 were measured using Western blotting of whole cervical spinal cord segments at C5. hGRPs did not slow the loss of intraspinal GLT1 protein levels compared to hF controls (D). Asterisks denote regions with large numbers of transplant-derived cells, but no GLT1 expression. Scale bars: 200 mm. doi:10.1371/journal.pone.0025968.g007",
  "captionBoundary": {
    "x1": 58.05181884765625,
    "x2": 554.2454833984375,
    "y1": 681.816162109375,
    "y2": 730.5450439453125
  },
  "figType": "Figure",
  "imageText": [],
  "name": "7",
  "page": 9,
  "regionBoundary": {
    "x1": 57.599999999999994,
    "x2": 382.08,
    "y1": 336.47999999999996,
    "y2": 668.16
  },
  "renderDpi": 150,
  "renderURL": "C:\\Users\\MSI\\OneDrive\\Documents\\Desktop\\5idma\\FrontBackPFE\\back\\output\\upload_1748292194_23796_pone.0025968\\image\\upload_1748292194_23796_pone.0025968-Figure7-1.png"
}, {
  "caption": "Figure 11. Cohort #3: ‘‘high dose’’ hGRP transplantation with FK-506/Rapamycin did not protect respiratory function or cervical motor neurons. Greater cell survival was found with the ‘‘high dose’’ transplants compared to ‘‘low dose’’ transplants, with a greater proportion of cells localizing to gray matter than white matter (A). Transplant-derived cells migrated from injection sites up to distances of 6 mm (B). All SOD1G93A animals had significantly reduced phrenic CMAP amplitudes at 130 days of age, however, there was no significant difference between hGRP and hF groups (C). There was no difference in cervical motor neuron survival between mice receiving hGRP and hF transplants at disease endstage (D). doi:10.1371/journal.pone.0025968.g011",
  "captionBoundary": {
    "x1": 58.05350112915039,
    "x2": 554.2620239257812,
    "y1": 395.5169677734375,
    "y2": 444.302734375
  },
  "figType": "Figure",
  "imageText": [],
  "name": "11",
  "page": 13,
  "regionBoundary": {
    "x1": 57.599999999999994,
    "x2": 381.12,
    "y1": 59.519999999999996,
    "y2": 382.08
  },
  "renderDpi": 150,
  "renderURL": "C:\\Users\\MSI\\OneDrive\\Documents\\Desktop\\5idma\\FrontBackPFE\\back\\output\\upload_1748292194_23796_pone.0025968\\image\\upload_1748292194_23796_pone.0025968-Figure11-1.png"
}, {
  "caption": "Table 1. Summary of Experimental Findings: Human Glial-Restricted Progenitor Transplantation into Cervical Spinal Cord of the SOD1G93A Mouse Model of ALS.",
  "captionBoundary": {
    "x1": 64.06300354003906,
    "x2": 554.217529296875,
    "y1": 66.7724609375,
    "y2": 81.69451904296875
  },
  "figType": "Table",
  "imageText": ["doi:10.1371/journal.pone.0025968.t001", "p.0.05", "for", "all", "analyses", "p.0.05", "for", "all", "analyses", "p.0.05", "for", "all", "analyses", "n", "22", "16", "20", "20", "12", "11", "2.95", "+/2", "0.1", "2.98", "+/2", "0.1", "6.1", "+/2", "0.4", "Cervical", "Motor", "Neurons/", "Section", "ND", "ND", "5.6", "+/2", "0.1", "3.3", "+/2", "0.7", "2.7", "+/2", "0.4", "4.5", "+/2", "0.6", "CMAPs", "(mV)", "ND", "ND", "4.3", "+/2", "0.7", "15.0", "+/2", "2.8", "15.3", "+/2", "3.2", "18.8", "+/2", "1.7", "18.1", "+/2", "2.7", "26.3", "+/2", "3.3", "Duration", "(Days)", "24.5", "+/2", "2.5", "106.6", "+/2", "15.7", "112.9", "+/2", "12.9", "117.4", "+/2", "1.7", "117.5", "+/2", "0.1", "112.3", "+/2", "2.8", "Forelimb", "Onset", "(Days)", "111.7", "+/2", "2.4", "101.2", "+/2", "13.3", "99.4", "+/2", "14.4", "108.6", "+/2", "2.1", "106.8", "+/2", "1.7", "94.4", "+/2", "3.6", "Hindlimb", "Onset", "(Days)", "94.5", "+/2", "2.3", "122.5", "+/14.1", "119.0", "+/2", "1.9", "127.9", "+/2", "1.9", "125.4", "+/2", "2.3", "121.0", "+/2", "2.2", "Survival", "(Days)", "119.0", "+/2", "1.9", "Cell", "Type", "Human", "Fibroblasts", "Q", "Cells", "Human", "Fibroblasts", "Q", "Cells", "Human", "Fibroblasts", "Q", "Cells", "Age", "at", "Txn", "(Days)", "50–60", "50–60", "50–60", "50–60", "50–60", "50æ60", "‘‘High", "Dose’’", "Transplantation", "150,000", "cells/site", "4", "sites/spinal", "cord", "‘‘Low", "Dose’’", "Transplantation", "50,000", "cells/site", "4", "sites/spinal", "cord", "Cell", "Dose", "‘‘Low", "Dose’’", "Transplantation", "50,000", "cells/site", "4", "sites/spinal", "cord", "FK-506/", "Rapamycin", "(I.P.)", "1", "mg/kg", "each", "daily", "FK-506/", "Rapamycin", "(I.P.)", "1", "mg/kg", "each", "daily", "Immune", "Suppression", "Cyclosporin", "A", "(Sub-Q)", "10", "mg/kg", "daily", "Cohort", "#1", "Cohort", "#2", "Cohort", "#3"],
  "name": "1",
  "page": 2,
  "regionBoundary": {
    "x1": 63.839999999999996,
    "x2": 552.0,
    "y1": 81.6,
    "y2": 367.2
  },
  "renderDpi": 150,
  "renderURL": "C:\\Users\\MSI\\OneDrive\\Documents\\Desktop\\5idma\\FrontBackPFE\\back\\output\\upload_1748292194_23796_pone.0025968\\image\\upload_1748292194_23796_pone.0025968-Table1-1.png"
}, {
  "caption": "Table 2. Antibody Details.",
  "captionBoundary": {
    "x1": 64.06300354003906,
    "x2": 166.76840209960938,
    "y1": 552.0069580078125,
    "y2": 556.4407958984375
  },
  "figType": "Table",
  "imageText": ["doi:10.1371/journal.pone.0025968.t002", "GLT1", "Astrocyte", "Glutamate", "Transporter", "Rothstein", "Lab", "Rabbit", "Polyoclonal", "1:500", "Iba1", "Microglia", "Wako", "Rabbit", "Polyoclonal", "1:200", "Synapsin", "Pre-synaptic", "Terminals", "BD", "Bio", "Rabbit", "Polyoclonal", "1:100", "Ki67", "Proliferating", "Cells", "Lab", "Vision", "Rabbit", "Polyoclonal", "1:400", "Olig2", "Oligodendrocyte", "Lineage", "Millipore", "Rabbit", "Polyoclonal", "1:200", "GFAP", "Astrocytes", "Dako", "Rabbit", "Polyoclonal", "1:400", "ChAT", "Motor", "Neurons", "Millipore", "Mouse", "Monoclonal", "1:500", "bIIITubulin", "Neurons", "Covance", "Rabbit", "Polyoclonal", "1:100", "A2B5", "Glial-Restricted", "Precursors", "Millipore", "Mouse", "Monoclonal", "1:500", "Nestin", "Undifferentiated", "Neural", "Precursor", "Pharmingen", "Mouse", "Monoclonal", "1:1,000", "Antibody", "Target", "of", "Recognition", "Manufacturer", "Species", "Dilution"],
  "name": "2",
  "page": 2,
  "regionBoundary": {
    "x1": 63.839999999999996,
    "x2": 553.92,
    "y1": 556.3199999999999,
    "y2": 732.48
  },
  "renderDpi": 150,
  "renderURL": "C:\\Users\\MSI\\OneDrive\\Documents\\Desktop\\5idma\\FrontBackPFE\\back\\output\\upload_1748292194_23796_pone.0025968\\image\\upload_1748292194_23796_pone.0025968-Table2-1.png"
}, {
  "caption": "Figure 10. Cohort #2: ‘‘low dose’’ hGRP transplantation with FK-506/Rapamycin did not protect respiratory function or cervical motor neurons. All SOD1G93A animals had significantly reduced phrenic CMAP amplitudes at 120 days of age (A), demonstrating that SOD1G93Amediated disease results in compromised respiratory function; however, there was no significant difference between hGRP and hF groups (B). Cervical motor neurons (denoted by arrowheads) were counted throughout the cervical enlargement in cresyl violet stained sections (C). There was no difference in cervical motor neuron survival between mice receiving hGRP and hF transplants at disease endstage (D). Scale bars: 50 mm. doi:10.1371/journal.pone.0025968.g010",
  "captionBoundary": {
    "x1": 58.050811767578125,
    "x2": 554.2621459960938,
    "y1": 681.8728637695312,
    "y2": 730.658447265625
  },
  "figType": "Figure",
  "imageText": [],
  "name": "10",
  "page": 12,
  "regionBoundary": {
    "x1": 57.599999999999994,
    "x2": 381.12,
    "y1": 310.56,
    "y2": 668.16
  },
  "renderDpi": 150,
  "renderURL": "C:\\Users\\MSI\\OneDrive\\Documents\\Desktop\\5idma\\FrontBackPFE\\back\\output\\upload_1748292194_23796_pone.0025968\\image\\upload_1748292194_23796_pone.0025968-Figure10-1.png"
}, {
  "caption": "Figure 5. Cohort #2: hGRPs with FK-506/Rapamycin did not differentiate into neurons in SOD1G93A cervical spinal cord. HuNA+ hGRP transplant-derived cells did not differentiate into bIII-Tubulin+ neurons (A–B). At disease endstage, less than 1% of all HuNA+ cells co-expressed bIIITubulin (F). HuNA+ cells spatially interacted with ChAT+ motor neurons (C–D) and synapsin+ pre-synaptic sites (E) within the spinal cord of SOD1G93A mice. Scale bars: A–B, E 50 mm; C-D 25 mm. doi:10.1371/journal.pone.0025968.g005",
  "captionBoundary": {
    "x1": 58.051483154296875,
    "x2": 554.2443237304688,
    "y1": 691.3971557617188,
    "y2": 731.225341796875
  },
  "figType": "Figure",
  "imageText": [],
  "name": "5",
  "page": 7,
  "regionBoundary": {
    "x1": 57.599999999999994,
    "x2": 411.35999999999996,
    "y1": 148.79999999999998,
    "y2": 678.24
  },
  "renderDpi": 150,
  "renderURL": "C:\\Users\\MSI\\OneDrive\\Documents\\Desktop\\5idma\\FrontBackPFE\\back\\output\\upload_1748292194_23796_pone.0025968\\image\\upload_1748292194_23796_pone.0025968-Figure5-1.png"
}, {
  "caption": "Figure 6. Cohort #2: hGRPs with FK-506/Rapamycin differentiated into astrocytes in SOD1G93A cervical spinal cord. Transplanted HuNA+ hGRPs differentiated into GFAP+ astrocytes by disease endstage in gray matter both near the injection site (A) and at distances up to 6 mm (B: image represents region with migrating cells approximately 3 mm caudal to the injection site), as well as in white matter (C). At disease endstage, approximately 50–80% of all HuNA+ cells co-expressed the astrocyte marker GFAP at sites within 1 mm rostral or caudal of the injection sites, regardless of whether cells were found in gray (A) or white (C) matter (D). This percentage decreased at greater distances from the injection sites (B, D). In addition to the pan-GFAP marker, transplanted-derived astrocytes were labeled with the human-specific GFAP marker (E–F). Only a minor fraction (approximately 1%) of HuNA+ cells co-expressed the microglial marker, Iba1 (G–H). Arrowheads denote HuNA/GFAP double-labeled cells in panels A and C. Scale bars: 50 mm. doi:10.1371/journal.pone.0025968.g006",
  "captionBoundary": {
    "x1": 58.0518798828125,
    "x2": 554.2933349609375,
    "y1": 654.7168579101562,
    "y2": 730.3749389648438
  },
  "figType": "Figure",
  "imageText": [],
  "name": "6",
  "page": 8,
  "regionBoundary": {
    "x1": 57.599999999999994,
    "x2": 441.12,
    "y1": 195.84,
    "y2": 641.28
  },
  "renderDpi": 150,
  "renderURL": "C:\\Users\\MSI\\OneDrive\\Documents\\Desktop\\5idma\\FrontBackPFE\\back\\output\\upload_1748292194_23796_pone.0025968\\image\\upload_1748292194_23796_pone.0025968-Figure6-1.png"
}, {
  "caption": "Figure 2. Cohort #2: hGRPs in combination with FK-506/Rapamycin survived and migrated in SOD1G93A cervical spinal cord. Unlike the lack of hGRP survival observed in SOD1G93A mice with CSA-based immune suppression, HuNA+ hGRP transplant-derived cells survived until disease endstage (up to 3 months post-transplantation) with FK-506/Rapamycin (A–D). Cells survived in both white and gray matter regions; however, a larger number of hGRP-derived cells were located in the white matter (C–D). On average, greater than 200,000 total cells survived in each spinal cord at endstage (C). HuNA+ cells also migrated both rostrally and caudally throughout the gray and white matter of the cervical spinal cord, up to distances of 0.6 cm from the injection sites; however, the vast majority of cells were located within 2 mm rostral and caudal of the injection sites (D). Scale bars: 500 mm. doi:10.1371/journal.pone.0025968.g002",
  "captionBoundary": {
    "x1": 58.05181884765625,
    "x2": 554.27294921875,
    "y1": 664.1846313476562,
    "y2": 730.8851318359375
  },
  "figType": "Figure",
  "imageText": [],
  "name": "2",
  "page": 4,
  "regionBoundary": {
    "x1": 57.599999999999994,
    "x2": 382.08,
    "y1": 312.47999999999996,
    "y2": 650.88
  },
  "renderDpi": 150,
  "renderURL": "C:\\Users\\MSI\\OneDrive\\Documents\\Desktop\\5idma\\FrontBackPFE\\back\\output\\upload_1748292194_23796_pone.0025968\\image\\upload_1748292194_23796_pone.0025968-Figure2-1.png"
}]